1) R&D Productivity Gap – how industry has to innovate

Over the past decade, drug prices have continuously risen as a result of high failure rates during research & development of novel drugs. In order to improve the efficiency of the pharmaceutical industry, R&D productivity has to significantly improve. This revolution in R&D productivity is likely to demand novel models of industry innovation, which leading R&D executives from the pharmaceutical and biotech industry will discuss during the GapSummit.

  • How can biotech and pharmaceutical companies improve R&D productivity in the future?




2) Digital Healthcare & Personalized Medicine Gap

The healthcare sector increasingly recognizes the advent of personalized medicine. In particular, novel technologies to advance digital health have created new avenues to monitor individual patients and to identify early symptoms of human diseases. It is thus no surprise that established tech companies including Google, Apple and Amazon are currently expanding their focus on healthcare and biotech. In addition, the genomics era and cutting-edge diagnostic tools have revolutionized targeted therapy. However, these advances have resulted in numerous challenges including
patient responsibility, treatment costs and continuous accumulation of Big Data.

Digital Health

  • How will digital technologies revolutionize healthcare?
  • How will the roles and responsibilities of the patient change?

Personalised Medicine

  • What role will advances in genomics and diagnostics play in driving personalized medicine?
  • What are the risks of ever-growing patient information?


3) Sustainability Gap

Food and energy supply for a growing population and climate change are key issues to be resolved in the very near future. Novel technologies and biotech ventures are a prerequisite to achieving global sustainability. We will focus on advances in agricultural biotechnology, particularly in developing countries, and how genetically modified crops are contributing to the advent of the second green revolution. Over the past years, gene editing has also been applied to improve yields of food supply other than crops. Besides the food industry, numerous biotech ventures are developing innovative solutions to develop biofuels, biomaterials and alternative energy sources to address the global energy crisis. What role can biotechnology play in the attempt to solve these worldwide challenges?


  • What role can agri-tech play in the attempt to solve the global food crisis?

White biotechnology

  • How can the industrial biotech sector be revolutionized to make our planet more sustainable in the future?


4) Drug Affordability Gap

Drug pricing is a common debate in the pharmaceutical and biotech industry and has certainly contributed to the negative reputation of Big Pharma companies. During the GapSummit 2018, we will discuss drug affordability and global accessibility. Many life-saving medicines are inaccessible for millions of patients across the world, and in particular across low-income countries. The aim of this debate will be to discuss the process of global drug pricing, the justification of treatment costs and the moral responsibility of the pharmaceutical industry to prioritize patients’ lives over stakeholder interests.

  • How does drug pricing need to change in the future to provide affordable life- saving drugs to patients across the world?




5) Young Entrepreneurs

The GapSummit 2018 will welcome 100 Leaders of Tomorrow from across the world, who share a passion for biotechnology and wish to drive the global bio-economy in the future. Many of these young talents are aspiring biotech entrepreneurs and share a strong ambition to found an innovative start-up. During the GapSummit, young bio-entrepreneurs will share their experience of founding and developing a start-up venture. They will discuss their personal journeys with the 100 Leaders of Tomorrow. How do I, as an ambitious entrepreneur, attract funding from investors?

  • How do I find the right people to develop my business?




6) Road from Academia to Industry

Many young bio-entrepreneurs have a strong academic research background. Often, these experiences heavily influence the identification of a gap in the market and the subsequent development of a new technology. However, realizing the translational potential of new discoveries provides a very different challenge to the scientific development. Research pioneers, serial entrepreneurs and industry leaders with academic background will provide insight into their experiences and give advice on translating your academic discoveries into a start-up.

  • How would you drive the early translational development of a novel application or technology that was born in an academic laboratory?



7) Funding Gap

This Gap will focus on the funding opportunities for young biotech start-ups. As a young bio-entrepreneur, raising funding throughout the early stages of the venture is a crucial yet daunting task. We will discuss sources of funding in the biotech industry and beyond. Funding experts will include angel investors, venture capitalists and corporate investors. The expert panel will not only include investors, but also biotech and pharma executives sharing their views on funding opportunities available to young start-ups.

  • As a young bio-entrepreneur, how do you convince an investor to support you?